Drug Database · Clinicians

Cinnarizine + Dimenhydrinate

Brands (1) DimezineShow all

Antihistamine (aminoalkyl ether) / antivertigo PH FDA category
Fixed-dose combination.

Rx · Prescription drug1 PH product
Dispensing: Prescription (Rx) Last updated: Audience: Licensed health professionals
US label not yet available for this generic. Check the Philippine package insert (linked in the products table where the FDA has published one).

Component information

No US or EU label exists for this exact combination, so information is shown for each component.

  • Use: Motion sickness (adults) renalcarematters.com, reviewed

    Kidney dosing: Cinnarizine (single-agent)
    Show full dosing details
    CrCl ≥60 mL/min
    Motion sickness: 30 mg 2 hours before travel, then 15 mg every 8 hours during the journey (SmPC).
    CrCl 30–59 mL/min
    No specific studies in kidney impairment; the SmPC says to use with care. Use with caution and specialist judgment.
    CrCl 15–29 mL/min
    No specific studies in kidney impairment; the SmPC says to use with care. Use with caution and specialist judgment.
    CrCl <15 mL/min (not on dialysis)
    No specific studies in kidney impairment; the SmPC says to use with care. Use with caution and specialist judgment.
    Hemodialysis (intermittent)
    Not studied in dialysis; no dose given.
    Peritoneal dialysis
    Not studied in dialysis; no dose given.
    CRRT
    Not studied in dialysis; no dose given.
    • Dialyzable? Not stated (91% protein-bound).
    • Monitoring Sedation (worse with alcohol and central nervous system depressants); extrapyramidal symptoms and parkinsonism, especially in older adults on long-term use (SmPC 4.4, 4.8).

    From the Cinnarizine monograph (renalcarematters.com, reviewed).

  • Use: Uses for prevention and treatment of these symptoms associated with motion sickness: nausea vomiting dizziness US FDA label

Note: Fixed-dose combinations may not allow the dose changes advised for each component; check the strength and use the single agents if a component needs adjusting.

Dosing: Altered kidney function

No kidney-specific text is available from the US label for this generic yet. Check the Philippine package insert in the products table.

Kidney dosing for each component (single-agent) is shown under Component information.

Kidney-specific guidance from renalcarematters.com: in preparation.

Dosage forms

Philippines

  • Tablet: 40 mg/20 mg

Registered products in the Philippines

1 product registered with the Food and Drug Administration (FDA) Philippines list Cinnarizine + Dimenhydrinate as the generic name. Registration status changes; confirm a product's current status on the FDA portal before relying on it.

Verify on PH FDA portal

Philippine FDA-registered products for Cinnarizine + Dimenhydrinate
Package insert
DimezineDimenhydrinate + Cinnarizine
40mg/20mg TabletAlu/Alu Blister Pack x 10's Box of 30's
Rx
Ajanta Pharma LimitedIndia
Ajanta Pharma Philippines, Inc.
DR-XY43105
Dec 19, 2028

Source: FDA Philippines product registration database. "Valid until" is the registration validity date listed by the FDA; a past date may mean a renewal is pending. Package insert links point to files published by the FDA.

Formulary and pricing (Philippines)

Check availability

Prices and stock vary by branch; renalcarematters.com does not sell medicines or receive payment from pharmacies.

References

  1. Food and Drug Administration Philippines. Verification portal (product registrations). https://verification.fda.gov.ph

This page shows official label and registry text only; no renalcarematters.com clinical summary has been approved for it yet.

For health professionals. This page is a reference compiled from public regulatory sources for licensed health professionals in the Philippines. Verify every product detail against the current Philippine package insert and the FDA Philippines registration record. Information here is not a substitute for clinical judgment and does not replace the prescribing information approved for the specific product you dispense or prescribe.

Last updated: .